104 related articles for article (PubMed ID: 18459989)
1. Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction.
Tetzlaff ED; Correa AM; Komaki R; Swisher SG; Maru D; Ross WA; Ajani JA
Dis Esophagus; 2008; 21(7):575-81. PubMed ID: 18459989
[TBL] [Abstract][Full Text] [Related]
2. The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma.
Tetzlaff ED; Correa AM; Baker J; Ensor J; Ajani JA
Cancer; 2007 May; 109(10):1989-95. PubMed ID: 17397035
[TBL] [Abstract][Full Text] [Related]
3. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction.
Ajani JA; Correa AM; Walsh GL; Komaki R; Lee JH; Vaporciyan AA; Rice DC; Yao JC; Maru DM; Hofstetter WL; Phan AT; Swisher SG
Cancer; 2010 Apr; 116(7):1656-63. PubMed ID: 20143431
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapy.
Papaxoinis G; Kamposioras K; Germetaki T; Weaver JMJ; Stamatopoulou S; Nasralla M; Kordatou Z; Owen-Holt V; Anthoney A; Mansoor W
Acta Oncol; 2018 Jun; 57(6):790-798. PubMed ID: 29308947
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
6. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy.
Zareba P; Patterson L; Pandya R; Margel D; Hotte SJ; Mukherjee SD; Elavathil L; Daya D; Shayegan B; Pinthus JH
Urol Oncol; 2014 Oct; 32(7):975-80. PubMed ID: 25027682
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of thromboembolism in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.
Bosch DJ; Van Dalfsen QA; Mul VE; Hospers GA; Plukker JT
Am J Surg; 2014 Aug; 208(2):215-21. PubMed ID: 24534559
[TBL] [Abstract][Full Text] [Related]
9. Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer.
Clavier JB; Antoni D; Atlani D; Ben Abdelghani M; Schumacher C; Dufour P; Kurtz JE; Noel G
Dis Esophagus; 2014 Aug; 27(6):560-7. PubMed ID: 23106980
[TBL] [Abstract][Full Text] [Related]
10. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic events before esophagectomy for esophageal cancer do not result in worse outcomes.
Teman NR; Silski L; Zhao L; Kober M; Urba SC; Orringer MB; Chang AC; Lin J; Reddy RM
Ann Thorac Surg; 2012 Oct; 94(4):1118-24; discussion 1124-5. PubMed ID: 22858275
[TBL] [Abstract][Full Text] [Related]
12. Selective dose escalation of chemoradiotherapy for locally advanced esophageal cancer.
Seung SK; Smith JW; Ross HJ
Dis Esophagus; 2008; 21(7):589-95. PubMed ID: 18430177
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT
Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897
[TBL] [Abstract][Full Text] [Related]
14. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.
Wolfe WG; Vaughn AL; Seigler HF; Hathorn JW; Leopold KA; Duhaylongsod FG
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):749-55; discussion 755-6. PubMed ID: 8469009
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials.
Sohal DP; Rice TW; Rybicki LA; Rodriguez CP; Videtic GM; Saxton JP; Murthy SC; Mason DP; Phillips BE; Tubbs RR; Plesec T; McNamara MJ; Ives DI; Bodmann JW; Adelstein DJ
Dis Esophagus; 2015; 28(6):547-51. PubMed ID: 24849395
[TBL] [Abstract][Full Text] [Related]
17. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
18. Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis.
Burstow M; Kelly T; Panchani S; Khan IM; Meek D; Memon B; Memon MA
Dis Esophagus; 2009; 22(6):519-25. PubMed ID: 19302213
[TBL] [Abstract][Full Text] [Related]
19. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
[TBL] [Abstract][Full Text] [Related]
20. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
Javeri H; Arora R; Correa AM; Hofstetter WL; Lee JH; Liao Z; McAleer MF; Maru D; Bhutani MS; Swisher SG; Izzo JG; Ajani JA
Cancer; 2008 Sep; 113(6):1302-8. PubMed ID: 18623381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]